Skip to content
20-F/A

Annual Report (Foreign)

Telix Pharmaceuticals Limited TLPPF TLX

0001140361-26-010554

← back to feed
Filed
Mar 20, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 31, 2025 338.78M sh